Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice

[1]  H. Meltzer,et al.  The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus , 2011, Brain Research Bulletin.

[2]  B. Pollock,et al.  Clozapine and Global Cognition in Schizophrenia , 2010, Journal of clinical psychopharmacology.

[3]  N. Tanimoto,et al.  Detection of behavioral alterations and learning deficits in mice lacking synaptophysin , 2009, Neuroscience.

[4]  Jared W. Young,et al.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. , 2009, Pharmacology & therapeutics.

[5]  D. Christensen,et al.  α7 Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment , 2009, Neuropharmacology.

[6]  F. Conti,et al.  Acute phencyclidine administration reduces extracellular glutamate levels and the expression of synaptophysin and SNAP-25 in rat frontal cortex , 2009, Schizophrenia Research.

[7]  A. Hannan,et al.  Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation. , 2009, The international journal of neuropsychopharmacology.

[8]  J. Nacher,et al.  Dopamine acting through D2 receptors modulates the expression of PSA-NCAM, a molecule related to neuronal structural plasticity, in the medial prefrontal cortex of adult rats , 2008, Experimental Neurology.

[9]  A. Kuzmin,et al.  Repeated low dose of phencyclidine administration impairs spatial learning in mice: Blockade by clozapine but not by haloperidol , 2008, European Neuropsychopharmacology.

[10]  H. Möller,et al.  Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[11]  T. Robinson,et al.  Persistent Alterations in Cognitive Function and Prefrontal Dopamine D2 Receptors Following Extended, but Not Limited, Access to Self-Administered Cocaine , 2008, Neuropsychopharmacology.

[12]  M V Ovanesov,et al.  Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia , 2008, Molecular Psychiatry.

[13]  B. Grayson,et al.  Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat , 2007, Behavioural Brain Research.

[14]  Yukihiro Noda,et al.  Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment , 2007, Neurochemistry International.

[15]  B. Moghaddam,et al.  Fine-Tuning of Awake Prefrontal Cortex Neurons by Clozapine: Comparison With Haloperidol and N-Desmethylclozapine , 2007, Biological Psychiatry.

[16]  Marco Capogna,et al.  A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse , 2007, Proceedings of the National Academy of Sciences.

[17]  M. Torres-Ramos,et al.  GLT‐1 down‐regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up‐regulation , 2006, Journal of neurochemistry.

[18]  M. Didriksen,et al.  Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment. , 2006, European journal of pharmacology.

[19]  A. Phillips,et al.  Selective effects of typical antipsychotic drugs on SNAP-25 and synaptophysin in the hippocampal trisynaptic pathway. , 2006, The international journal of neuropsychopharmacology.

[20]  P. Maycox,et al.  Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons , 2006, Molecular and Cellular Neuroscience.

[21]  Aryeh Routtenberg,et al.  Spatial learning induces presynaptic structural remodeling in the hippocampal mossy fiber system of two rat strains , 2006, Hippocampus.

[22]  H. Meltzer,et al.  N-Desmethylclozapine, a Major Metabolite of Clozapine, Increases Cortical Acetylcholine and Dopamine Release In Vivo Via Stimulation of M1 Muscarinic Receptors , 2005, Neuropsychopharmacology.

[23]  Yuko Fujita,et al.  Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol. , 2005, European journal of pharmacology.

[24]  J. Lieberman,et al.  The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia , 2005, Neuroscience Letters.

[25]  R. Rodriguiz,et al.  Neural Cell Adhesion Molecule-Secreting Transgenic Mice Display Abnormalities in GABAergic Interneurons and Alterations in Behavior , 2005, The Journal of Neuroscience.

[26]  J. Dudman,et al.  Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat , 2005, Biological Psychiatry.

[27]  R. Roesler,et al.  Impairing effects of chronic haloperidol and clozapine treatment on recognition memory: possible relation to oxidative stress , 2005, Schizophrenia Research.

[28]  Paul J. Harrison,et al.  Schizophrenia: a genetic disorder of the synapse? , 2005, BMJ : British Medical Journal.

[29]  N. Jing,et al.  SNAP‐25 in hippocampal CA1 region is involved in memory consolidation , 2004, The European journal of neuroscience.

[30]  D. Weinberger,et al.  Effects of Chronic Haloperidol and Clozapine Treatment on Neurogenesis in the Adult Rat Hippocampus , 2004, Neuropsychopharmacology.

[31]  F. Benfenati,et al.  Synaptophysin: leading actor or walk-on role in synaptic vesicle exocytosis? , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[32]  P. Jeffrey Conn,et al.  N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-d-aspartate receptor activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Paul J. Harrison,et al.  Long‐term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism , 2003, The European journal of neuroscience.

[34]  J. Kleinman,et al.  Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development , 2003, Molecular Psychiatry.

[35]  P. Visscher,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. , 2003, American journal of human genetics.

[36]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[37]  M. Vawter,et al.  SNAP-25 reduction in the hippocampus of patients with schizophrenia , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[38]  K. Nylen,et al.  Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration , 2002, Brain Research.

[39]  S. Heckers,et al.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia , 2001, Biological Psychiatry.

[40]  S. Fatemi,et al.  Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia , 2001, Neuroreport.

[41]  Paul J. Harrison,et al.  Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia , 2001, Hippocampus.

[42]  Zin Z. Khaing,et al.  BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs , 2001, The European journal of neuroscience.

[43]  Eric J. Nestler,et al.  Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus , 2000, The Journal of Neuroscience.

[44]  Paul J. Harrison,et al.  Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain , 2000, Synapse.

[45]  Paul J. Harrison,et al.  Synaptophysin gene expression in schizophrenia , 2000, British Journal of Psychiatry.

[46]  E. Castrén,et al.  Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents , 2000, Journal of Molecular Neuroscience.

[47]  Paul J. Harrison,et al.  Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections , 1999, Neuroscience.

[48]  Y. Hirasawa,et al.  Distribution of synaptosomal-associated protein 25 in nerve growth cones and reduction of neurite outgrowth by botulinum neurotoxin A without altering growth cone morphology in dorsal root ganglion neurons and PC-12 cells , 1999, Neuroscience.

[49]  G. Higgins,et al.  Reduced synaptophysin immunoreactivity in the dentate gyrus of prepulse inhibition-impaired isolation-reared rats , 1999, Brain Research.

[50]  K. Hashimoto,et al.  Effect of chronic haloperidol treatment on synaptic protein mRNAs in the rat brain. , 1998, Brain research. Molecular brain research.

[51]  J. Bobich,et al.  A sequential view of neurotransmitter release , 1998, Brain Research Bulletin.

[52]  R. Roth,et al.  Subchronic Phencyclidine Administration Increases Mesolimbic Dopaminergic System Responsivity and Augments Stress- and Psychostimulant-Induced Hyperlocomotion , 1998, Neuropsychopharmacology.

[53]  Nora I. Perrone-Bizzozero,et al.  Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia , 1998, Biological Psychiatry.

[54]  L. Glantz,et al.  Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. , 1997, Archives of general psychiatry.

[55]  Paul J. Harrison,et al.  Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes , 1997, Molecular Psychiatry.

[56]  K. Davis,et al.  Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. , 1997, Archives of general psychiatry.

[57]  M. Wilson,et al.  SNAP-25 and synaptotagmin involvement in the final Ca(2+)-dependent triggering of neurotransmitter exocytosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Paul J. Harrison,et al.  Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia , 1995, Neuroscience.

[59]  M. Catsicas,et al.  Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo , 1993, Nature.

[60]  H. Mizoguchi,et al.  Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidine. , 2007, Journal of pharmacological sciences.

[61]  S. Eastwood.  The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? , 2004, International review of neurobiology.

[62]  D. Braus,et al.  Hippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatment , 2004, Journal of Neural Transmission.

[63]  D. Keegan,et al.  Expression of brain‐derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs , 2003, Journal of neuroscience research.

[64]  J. Kleinman,et al.  Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia , 2002, Molecular Psychiatry.

[65]  A. Phillips,et al.  Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness , 2002, Molecular Psychiatry.

[66]  G. Teuchert-Noodt,et al.  Adult treatment with haloperidol increases dentate granule cell proliferation in the gerbil hippocampus , 1998, Journal of Neural Transmission.